Healthcare use and RT‐PCR testing during the first wave of the COVID‐19 pandemic in Japan
Abstract Background Rapid testing, tracing, and isolation among symptomatic patients are the standard for controlling the COVID‐19. However, during spring 2020, Japan employed a RT‐PCR test policy by using a guideline, which was used for the public to visit hospitals or clinics when they had mild symptoms for 4 days or longer (“4‐day rule”) among low‐risk patients. It is unknown of patients’ experience of healthcare use and testing during the period under the guideline. Thus, we investigated the healthcare visiting and testing among patients who developed cold‐like symptoms during the period. Methods Our survey was conducted online in September 2020 to a nationally representative sample of adults throughout Japan. We investigated the public's understanding of the guideline. In addition, we asked their experience with healthcare use and testing if they had noticed new‐onset cold‐like symptoms. Results Of 2,137 people surveyed, 1,698 (79.5%) recognized the guidelines, but 422 people (19.7%) misunderstood. There were 144 (6.7% of 2,137 people) who developed cold‐like symptoms, and many of them experienced difficulties in getting through telephone calls to a public health center, and 25 (17% of 144 people) visited healthcare institutions. Of these 25 symptomatic patients, 15 (60%) could not receive testing because of decisions by physicians (14 patients) or a local public health center (1 patient). Conclusion There was a low use of healthcare and testing among symptomatic patients during the first wave of the pandemic in Japan. Testing capacity should be increased to provide effective care for patients with suspected COVID‐19 in Japan..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Journal of General and Family Medicine - 23(2022), 1, Seite 3-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Masaru Kurihara [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID‐19 |
|---|
| doi: |
10.1002/jgf2.512 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ003073599 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ003073599 | ||
| 003 | DE-627 | ||
| 005 | 20230502145905.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jgf2.512 |2 doi | |
| 035 | |a (DE-627)DOAJ003073599 | ||
| 035 | |a (DE-599)DOAJe4a72eabc5be4ee1b6b77277da1ca4bc | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Masaru Kurihara |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Healthcare use and RT‐PCR testing during the first wave of the COVID‐19 pandemic in Japan |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Rapid testing, tracing, and isolation among symptomatic patients are the standard for controlling the COVID‐19. However, during spring 2020, Japan employed a RT‐PCR test policy by using a guideline, which was used for the public to visit hospitals or clinics when they had mild symptoms for 4 days or longer (“4‐day rule”) among low‐risk patients. It is unknown of patients’ experience of healthcare use and testing during the period under the guideline. Thus, we investigated the healthcare visiting and testing among patients who developed cold‐like symptoms during the period. Methods Our survey was conducted online in September 2020 to a nationally representative sample of adults throughout Japan. We investigated the public's understanding of the guideline. In addition, we asked their experience with healthcare use and testing if they had noticed new‐onset cold‐like symptoms. Results Of 2,137 people surveyed, 1,698 (79.5%) recognized the guidelines, but 422 people (19.7%) misunderstood. There were 144 (6.7% of 2,137 people) who developed cold‐like symptoms, and many of them experienced difficulties in getting through telephone calls to a public health center, and 25 (17% of 144 people) visited healthcare institutions. Of these 25 symptomatic patients, 15 (60%) could not receive testing because of decisions by physicians (14 patients) or a local public health center (1 patient). Conclusion There was a low use of healthcare and testing among symptomatic patients during the first wave of the pandemic in Japan. Testing capacity should be increased to provide effective care for patients with suspected COVID‐19 in Japan. | ||
| 650 | 4 | |a COVID‐19 | |
| 650 | 4 | |a guideline | |
| 650 | 4 | |a healthcare use | |
| 650 | 4 | |a novel coronavirus | |
| 650 | 4 | |a RT‐PCR test | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Kazuhiro Kamata |e verfasserin |4 aut | |
| 700 | 0 | |a Shun Nakahara |e verfasserin |4 aut | |
| 700 | 0 | |a Kyoko Kitazawa |e verfasserin |4 aut | |
| 700 | 0 | |a Shunzo Koizumi |e verfasserin |4 aut | |
| 700 | 0 | |a Yasuharu Tokuda |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of General and Family Medicine |d Wiley, 2017 |g 23(2022), 1, Seite 3-8 |w (DE-627)DOAJ00010597X |x 21897948 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:1 |g pages:3-8 |
| 856 | 4 | 0 | |u https://doi.org/10.1002/jgf2.512 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/e4a72eabc5be4ee1b6b77277da1ca4bc |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1002/jgf2.512 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2189-7948 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2022 |e 1 |h 3-8 | ||